Short answer
Chemed Corp (CHE) filed its Q3 2026 10-Q quarterly report on Oct 29, 2026 for the quarter ended Sep 30, 2026. Quarterly revenue was $691M (up 10.6% year over year) with net income of $72M.
Q3 2026 key financials · XBRL
- Revenue
- $691M
- +10.6% YoY · +2.6% QoQ
- Net income
- $72M
- +11.5% YoY · +5.8% QoQ
- Operating margin
- 14.0%
- EPS (diluted)
- $5.46
- +22.4% YoY · +6.4% QoQ
Source: XBRL data from the Chemed Corp (CHE) Q3 2026 10-Q on SEC EDGAR. USD.
Chemed Corp Q3 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Q3 revenue $690.9M, up 10.6% YoY from $624.9M, led by VITAS up 12.2%
- Gross margin 33.7% vs 32.0% YoY, adjusted EBITDA margin 19.4% vs 17.4%
- Best segment VITAS: revenue $457.4M, net income $65.7M, after-tax margin 14.4% vs 11.5%
- Worst segment Roto-Rooter: net income $30.1M vs $32.1M, after-tax margin 13.0% vs 14.8%
- Operating cash flow decreased $25.1M; debt rose $236.0M and treasury stock increased $400.0M from repurchases and acquisitions
- Outlook: no material FY2026 impact expected, but inflation, tariffs, fuel costs and Iran-related fuel pressures threaten future profitability
Risk Factors
- No material changes from the latest 10-K and prior 10-Q
- Carried-forward regulatory, operational, market, and financial risks remain applicable
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.